Ditch the painkillers! While they can provide temporary relief, there are other ways to numb pain without medication. Find ...

“I believe JOURNAVX could redefine the management of pain and become a foundational treatment option for people with all types of moderate-to-severe acute pain, where options aside from opioids ...

In the second world war, the physician Henry Beecher observed that some of his soldier patients, despite being injured on the ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Writing in the journal Frontiers in Conservation Science, former Montana bear management specialist ... Administration approved a new pain medicine called Journavx (suzetrigine), made by Vertex ...

A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...

Dr. Jason Busse and I are pleased to present a project at McMaster on the safe and effective use of opioids for chronic pain ...

A new Mount Sinai study provides compelling evidence that exercise can significantly help the mental well-being of millions ...

Dr. Abhishek Reddy and Dr. Joe Fuhrman stop by Houston Life to discuss their innovative approach to pain management.

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine), an oral NaV1.8 inhibitor, as a treatment for acute pain, representing ...